Captagon: A comprehensive bibliometric analysis (1962-2024) of its global impact, health and mortality risks

• Egile Nagusiak: Seraphina Fong (Egilea), Alessandro Carollo (Egilea), Andrea Rossato (Egilea), Elisabeth Prevete (Egilea), Gianluca Esposito (Egilea), Ornella Corazza (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2024-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Captagon is a synthetic stimulant combining amphetamine and theophylline. Initially introduced in 1961 as a treatment for hyperactivity, depression, and narcolepsy, Captagon was later classified as a Schedule 1 controlled substance due to its addictive and hallucinogenic properties. Despite its glob...